For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211203:nRSC5768Ua&default-theme=true
RNS Number : 5768U Venture Life Group PLC 03 December 2021
3 December 2021
VENTURE LIFE GROUP PLC
("Venture Life" "VLG" or the "Group")
Director Dealings
Venture Life Group plc (AIM: VLG), a leader in developing, manufacturing and
commercialising products for the international self-care market, announces
that between 1 December 2021 and 3 December 2021 certain of the Company's
Directors purchased shares as follow:
Name Date of Purchase No. of Shares Purchased Price per share Resultant holding post transaction (%)
Jerry Randall, 3 December 2021 100,000 34.99p 1,984,865 (1.5%)
Chief Executive Officer
Sharon Collins, 3 December 2021 100,000 34.99p 1,109,977 (0.9%)
Chief Commercial Officer
Gianluca Braguti, 3 December 2021 100,000 34.99p 3,642,730 (2.9%)
Chief Manufacturing Officer
Carl Dempsey, 1 December 2021 28,500 34.48 48,500 (0.04%)
Non-Executive Director
For further information, please contact:
Venture Life Group PLC +44 (0) 1344 578004
Jerry Randall, Chief Executive Officer
Daniel Wells, Chief Financial Officer
Cenkos Securities plc (Nomad and Broker) +44 (0) 20 7397 8900
Stephen Keys / Camilla Hume
Russell Kerr / Michael Johnson (Sales)
N+1 Singer (Joint Broker) +44 (0) 20 7496 3000
Shaun Dobson / Alaina Wong (Corporate Finance)
Jonathan Dighe (Sales)
About Venture Life (www.venture-life.com (http://www.venture-life.com/) )
Venture Life is an international consumer self-care company focused on
developing, manufacturing and commercialising products for the global
self-care market. With operations in the UK, Italy, The Netherlands and
Sweden, the Group's product portfolio includes some key products such as the
UltraDEX and Dentyl oral care product ranges, the Balance Active range in the
area of women's intimate healthcare, the Lift and Glucogel product ranges for
hypoglycaemia, products for fungal infections and proctology, and
dermo-cosmetics for addressing the signs of ageing. Its products are sold in
over 90 countries worldwide.
The products, which are typically recommended by pharmacists or healthcare
practitioners, are available primarily through pharmacies and grocery
multiples. In the UK and The Netherlands these are supplied direct by the
company to retailers, elsewhere they are supplied by the Group's international
distribution partners.
Through its two Development & Manufacturing operations in Italy and
Sweden, the Group also provides development and manufacturing services to
companies in the medical devices and cosmetic sectors.
The Company makes the following disclosures in accordance with article 19(3)
of the Market Abuse Regulation:
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Jerry Randall
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Venture Life Group plc
b) LEI 213800S8CZUPLAB2KC70
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.3p each in Venture Life Group plc
Identification code
GB00BFPM8908
b) Nature of the transaction Purchase of ordinary shares
c) Price(s) and volume(s) 100,000 ordinary shares at 34.99 pence per share
d) Aggregated information See above
- Aggregated volume
- Price
e) Date of the transaction 3 December 2021
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Sharon Collins
2 Reason for the notification
a) Position/status Chief Commercial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Venture Life Group plc
b) LEI 213800S8CZUPLAB2KC70
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.3p each in Venture Life Group plc
Identification code
GB00BFPM8908
b) Nature of the transaction Purchase of ordinary shares
c) Price(s) and volume(s) 100,000 ordinary shares at 34.99 pence per share
d) Aggregated information See above
- Aggregated volume
- Price
e) Date of the transaction 3 December 2021
f) Place of the transaction London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Gianluca Braguti
2 Reason for the notification
a) Position/status Chief Manufacturing Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Venture Life Group plc
b) LEI 213800S8CZUPLAB2KC70
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.3p each in Venture Life Group plc
Identification code
GB00BFPM8908
b) Nature of the transaction Purchase of ordinary shares
c) Price(s) and volume(s)
Price(s) Volume(s)
34.99 100,000
d) Aggregated information See above
- Aggregated volume
- Price
e) Date of the transaction 3 December 2021
f) Place of the transaction London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
See above
e)
Date of the transaction
3 December 2021
f)
Place of the transaction
London Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Carl Dempsey
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Venture Life Group plc
b) LEI 213800S8CZUPLAB2KC70
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.3p each in Venture Life Group plc
Identification code
GB00BFPM8908
b) Nature of the transaction Purchase of ordinary shares
c) Price(s) and volume(s)
Price(s) Volume(s)
34.48 28,500
d) Aggregated information See above
- Aggregated volume
- Price
e) Date of the transaction 1 December 2021
f) Place of the transaction London Stock Exchange
d)
Aggregated information
- Aggregated volume
- Price
See above
e)
Date of the transaction
1 December 2021
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFLFFRFILVIIL